SMO ClinPlus CO., LTD. — Investor Relations & Filings
SMO ClinPlus CO., LTD. is a professional Site Management Organization (SMO) providing comprehensive clinical trial site management services. The company specializes in supporting pharmaceutical, biotechnology, and medical device developers throughout the clinical development lifecycle. Core services include the provision of Clinical Research Coordinators (CRCs), site feasibility assessments, patient recruitment and retention strategies, and clinical trial data management. ClinPlus facilitates the execution of clinical trials by managing administrative and operational tasks at research sites, ensuring compliance with Good Clinical Practice (GCP) and regulatory requirements. With an extensive network of partner hospitals and research institutions, the company streamlines the clinical research process, enhances data quality, and accelerates project timelines for domestic and international sponsors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 普蕊斯(上海)医药科技开发股份有限公司2025年度募集资金存放、管理与使用情况专项报告的鉴证报告 | 2026-04-28 | Chinese | |
| 关于会计师事务所2025年度履职情况评估报告 | 2026-04-28 | Chinese | |
| 关于提请股东会授权董事会以简易程序向特定对象发行股票的公告 | 2026-04-28 | Chinese | |
| 董事会关于独立董事独立性情况的专项意见 | 2026-04-28 | Chinese | |
| 关于公司股东减持计划期限届满的公告 | 2026-04-19 | Chinese | |
| 关于公司股东减持股份预披露公告 | 2026-04-14 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40111279 | 普蕊斯(上海)医药科技开发股份有限公司2025年度募集资金存放、管理与使用情况专项报告的鉴证报告 | 2026-04-28 | Chinese | ||
| 40111253 | 关于会计师事务所2025年度履职情况评估报告 | 2026-04-28 | Chinese | ||
| 40111243 | 关于提请股东会授权董事会以简易程序向特定对象发行股票的公告 | 2026-04-28 | Chinese | ||
| 40111230 | 董事会关于独立董事独立性情况的专项意见 | 2026-04-28 | Chinese | ||
| 40111217 | 关于公司股东减持计划期限届满的公告 | 2026-04-19 | Chinese | ||
| 40111213 | 关于公司股东减持股份预披露公告 | 2026-04-14 | Chinese | ||
| 40111210 | 关于公司股东减持计划实施完成的公告 | 2026-03-17 | Chinese | ||
| 40111198 | 北京国枫（上海）律师事务所关于普蕊斯（上海）医药科技开发股份有限公司2026年第一次临时股东会的法律意见书 | 2026-03-13 | Chinese | ||
| 40111194 | 关于董事会完成换届选举及聘任公司高级管理人员、证券事务代表的公告 | 2026-03-13 | Chinese | ||
| 40111193 | 关于选举公司第四届董事会职工代表董事的公告 | 2026-03-13 | Chinese | ||
| 40111190 | 2026年第一次临时股东会决议公告 | 2026-03-13 | Chinese | ||
| 40111188 | 第四届董事会第一次会议决议公告 | 2026-03-13 | Chinese | ||
| 40111183 | 关于召开2026年第一次临时股东会提示性公告 | 2026-03-09 | Chinese | ||
| 40111180 | 关于召开2026年第一次临时股东会的通知 | 2026-02-25 | Chinese | ||
| 40111166 | 第三届董事会第十七次会议决议公告 | 2026-02-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
SMO ClinPlus CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56179/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56179 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56179 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56179 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56179}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SMO ClinPlus CO., LTD. (id: 56179)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.